Prevention of HMA failure a goal for high-risk MDS posttransplant
Pediatric News ,
Prognoses remain extremely poor after hypomethylating agents (HMAs) fail in patients with higher-risk myelodysplastic syndromes …
Comparison of risk stratification tools in predicting outcomes of patients with higher-risk myelodysplastic syndromes treated with azanucleosides
Overview of attention for article published in Leukemia, October 2015
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (85th percentile)
-
High Attention Score compared to outputs of the same age and source (87th percentile)
Readers on
- mendeley
- 39 Mendeley